CIK 0001628171 · Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472029180
- Phone
- 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-21 | Cislini Jeff General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −26,600 | 3,500 | ||
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +80,000 | $4.73 | $378K | 347,330 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −5,128 | $207.23 | $1.1M | 342,202 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −24,917 | $208.37 | $5.2M | 317,285 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −35,938 | $209.26 | $7.5M | 281,347 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −3,813 | $210.25 | $802K | 277,534 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −6,583 | $211.33 | $1.4M | 270,951 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −3,621 | $212.08 | $768K | 267,330 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −190 | $207.25 | $39K | 64,234 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −951 | $208.36 | $198K | 63,283 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −1,351 | $209.28 | $283K | 61,932 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −136 | $210.40 | $29K | 61,796 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −245 | $211.47 | $52K | 61,551 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −127 | $212.06 | $27K | 61,424 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −177 | $207.25 | $37K | 64,247 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −937 | $208.36 | $195K | 63,310 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −1,405 | $209.27 | $294K | 61,905 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −126 | $210.40 | $27K | 61,779 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −229 | $211.46 | $48K | 61,550 |
| 2026-08-21 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −126 | $212.06 | $27K | 61,424 |
Page 6 of 18 · 352 trades